BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)

NYU Langone Medical Center- Site Number : 8400102, New York

Investigational Site Number : 2760002, Berlin

Investigational Site Number : 3800003, Milan

Investigational Site Number : 3800001, Brescia

Investigational Site Number : 7240003, Madrid

Investigational Site Number : 7240002, Madrid

Investigational Site Number : 2500005, Toulouse

Investigational Site Number : 2500007, Bordeaux

Investigational Site Number : 3800004, Bologna

Investigational Site Number : 2760004, Essen

University of Wisconsin Hospitals and Clinics- Site Number : 8400003, Madison

Investigational Site Number : 2500001, Paris

Investigational Site Number : 2760001, Munich

Cedars-Sinai Medical Center- Site Number : 8400100, Los Angeles

University of California Los Angeles Medical Center- Site Number : 8400103, Los Angeles

Investigational Site Number : 2500002, Créteil

University of California San Francisco - Parnassus Heights- Site Number : 8400001, San Francisco

Massachusetts General Hospital- Site Number : 8400007, Boston

Brigham & Women's Hospital- Site Number : 8400004, Boston

Investigational Site Number : 1240101, Vancouver

Investigational Site Number : 1240001, Vancouver

Investigational Site Number : 1240002, London

Investigational Site Number : 1240003, Montreal

Investigational Site Number : 3800002, Rome

Investigational Site Number : 7240004, Barcelona

Investigational Site Number : 7520001, Huddinge

Investigational Site Number : 7520002, Uppsala